Digestive Endoscopy Unit, Humanitas Mater Domini, Castellanza, Varese, Italy.
Digestive Endoscopy Unit, Division of Gastroenterology, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.
Minerva Gastroenterol (Torino). 2022 Jun;68(2):177-185. doi: 10.23736/S2724-5985.21.02862-X. Epub 2021 Apr 19.
Lumen-apposing metal stents (LAMS) are recently introduced devices that allow to create anastomoses. The indications for LAMS placement are increasing and currently these stents can be used in multiple clinical situations such as endoscopic drainage of pancreatic fluid collections (PFCs), endoscopic ultrasound-guided choledochoduodenostomy (EUS-CDS), endoscopic ultrasound gallbladder drainage (EUS-GBD), endoscopic ultrasound gastrojejunostomy (EUS-GJ). Since their introduction, they have revealed to allow a higher rate of technical and clinical success, and potentially lower risk of adverse events (AEs) compared with previously available devices. Despite ongoing innovation, any advanced intervention carries risks of AEs. These AEs may occur during the deployment or can be delayed because of the consequent effects of the procedure and/or stent itself. This review represents an overview of current indications, technical and clinical results, with an extensive focus on safety issues related to placement and on long-term indwelling related ones.
lumen 对位金属支架(LAMS)是最近引入的一种能够创建吻合口的设备。LAMS 放置的适应证正在增加,目前这些支架可用于多种临床情况,如内镜下胰腺液体积聚引流(PFC)、内镜超声引导下胆肠吻合术(EUS-CDS)、内镜超声胆囊引流(EUS-GBD)、内镜超声胃空肠吻合术(EUS-GJ)。自引入以来,它们已被证明与以前可用的设备相比,具有更高的技术和临床成功率,以及潜在更低的不良事件(AE)风险。尽管不断创新,但任何先进的介入都存在 AE 的风险。这些 AE 可能在部署过程中发生,也可能因该过程和/或支架本身的后续影响而延迟。这篇综述概述了当前的适应证、技术和临床结果,并广泛关注与放置相关的安全性问题以及与长期留置相关的问题。